SPONSOR
Shanghai Chest Hospital
Total Trials
8
Recruiting
8
Phases
Phase 3, Phase 2
Conditions studied: Neoadjuvant ChemoimmunotherapyRobotic Pulmonary ResectionStage IIB-III NSCLCLung CancerNSCLCNSCLC Stage IVNSCLC, RecurrentEsophageal CancerSmall Cell Lung Cancer ( SCLC )Radiotherapy
Shanghai Chest Hospital is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC, Lung Cancer.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Chest Hospital
How many clinical trials has Shanghai Chest Hospital sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Shanghai Chest Hospital, of which 8 are actively recruiting participants. These trials cover conditions including Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Chest Hospital research focus on?
Shanghai Chest Hospital clinical trials span Neoadjuvant Chemoimmunotherapy, Robotic Pulmonary Resection, Stage IIB-III NSCLC, Lung Cancer, NSCLC, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Chest Hospital clinical trial?
To participate in a Shanghai Chest Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Chest Hospital trials with current recruitment status updated daily.
Clinical Trials by Shanghai Chest Hospital
NCT07528066
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Neoadjuvant Chemoimmunotherapy
NCT05494021
Recruiting
China Lung Cancer Screening (CLUS) Study Version 3.0
Lung Cancer
NCT05701787
Recruiting
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
NSCLC
NCT04135664 Phase 3
Recruiting
Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma
Esophageal Cancer
NCT07565532
Recruiting
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Small Cell Lung Cancer ( SCLC )
NCT06152107
Recruiting
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
Severe Emphysema
NCT05978193 Phase 2
Recruiting
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
NCT07564557
Recruiting
Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)
Non-small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology